A Proven and Simple Screening Test to accuratly detect CAD
We are seeing more and more data on the benefits of low oxLDL. Lower oxidized LDL promotes longevity.
Oxidized LDL Testing
National Screening Institute (NSI) has the exclusive worldwide rights to oxidized LDL and malondialdehyde (MDA)-modified LDL antibodies and corresponding technology developed by Professor Paul Holvoet at the University of Leuven, Belgium.
What is Oxidized LDL?
Oxidized LDL is the atherogenic form of LDL-cholesterol. It is a plaque-specific lipoprotein, found only in atherosclerotic plaques and not in normal artery walls.
About Our Test
We offer Antibodies for targets that are superior to existing biomarkers. The only blood test that reflects atherosclerotic disease activity in the arterial wall for greater accuracy.
Read the latest research on tissue‐type plasminogen activator (t‐PA) for the treatment of various thromboembolic diseases.
Read our peer-reviewed data demonstrating why oxidized LDL will become the biomarker of choice for the diagnosis and therapeutic monitoring.